EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B protein

Fuxuan Wang iD, Zhao Gao, Bo Chen, Zhengyuan Jiang, David M Renner, Jiaqi Li, Gideon Tolufashe, Yanming Du, Ju-Tao Guo iD, Jinhong Chang iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2505498122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Fuxuan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Baruch S. Blumberg Institute, Doylestown, PA 18902. Hauptthemen laut MEDLINE: Yellow fever virus, Viral Nonstructural Proteins, Antiviral Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Yellow fever virus (YFV) replicates its RNA genome in membranous vesicles derived from the invagination of endoplasmic reticulum membranes, designated as replication organelles (ROs). Nonstructural protein 4B (NS4B) of flaviviruses play essential roles in the biogenesis of ROs and evasion of innate immune responses. We report herein that the binding of an antiviral agent, acetic acid benzodiazepine (BDAA), to YFV NS4B not only rapidly inhibits YFV RNA synthesis, but also induces the activation of cytoplasmic double-stranded RNA (dsRNA)-sensing pathways to accelerate the apoptosis of infected cells. Genetic analyses revealed that all the three cytoplasmic dsRNA-sensing pathways contribute to YFV induction of apoptosis, whereas only retinoic acid-inducible gene I-like receptors and RNase L pathways are required for BDAA acceleration of infected cell death. Our findings support the notion that BDAA binding of NS4B impairs the integrity of ROs, leading to the inhibition of viral RNA synthesis and exposure of viral RNA replication intermediates for the activation of dsRNA sensors and acceleration of infected cell apoptosis. The unprecedented modes of action support the ongoing development of a potent BDAA derivative as a therapeutic agent of yellow fever that continues threatening the lives of millions of people.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Yellow fever virusViral Nonstructural ProteinsAntiviral AgentsHumansVirus ReplicationApoptosisYellow FeverRNA, Double-StrandedAnimalsRNA, ViralChlorocebus aethiops

Stichwörter der Autor:innen

NS4BRNA synthesisdsRNA-sensing pathwaysreplication organelleyellow fever virus

Substanzen

Viral Nonstructural ProteinsAntiviral AgentsNS4B protein, flavivirusRNA, Double-StrandedRNA, Viral

Autor:innen und Institutionen

  • Baruch S. Blumberg Institute, Doylestown, PA 18902.

ORCID-Profile: Fuxuan Wang, Ju-Tao Guo, Jinhong Chang

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Wang, F., Gao, Z., Chen, B., Jiang, Z., Renner, D. M., Li, J., Tolufashe, G., Du, Y., Guo, J. T., & Chang, J. (2025). Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B protein. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2505498122

Vancouver

Wang F, Gao Z, Chen B, Jiang Z, Renner DM, Li J, et al. Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B protein. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2505498122

BibTeX
@article{Wang2025,
  author = {Wang, Fuxuan and Gao, Zhao and Chen, Bo and Jiang, Zhengyuan and Renner, David M and Li, Jiaqi and Tolufashe, Gideon and Du, Yanming and Guo, Ju-Tao and Chang, Jinhong},
  title = {Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B protein},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2505498122}
}
Kostenlos starten →